The Next Cancer Hospital: Where India's Oncology Infrastructure Gap Meets Investor Opportunity
India faces a deepening oncology infrastructure crisis — 1.4 million new cancer cases annually, yet fewer than 200 dedicated cancer hospitals serve a population of 1.4 billion. This report maps the demand-supply gap across geographies, profiles the economics of dedicated cancer hospital formats, and identifies where the next wave of oncology infrastructure investment is most likely to generate both clinical impact and financial returns. Based on primary research across oncologists, hospital operators, and patients in 20 cities.
Free Report
The Next Cancer Hospital: Where India's Oncology Infrastructure Gap Meets Investor Opportunity
No spam. Instant download.
Key Findings
- 1
India registers 1.4 million new cancer cases annually — over 70% are diagnosed at Stage III or IV due to late detection
- 2
Fewer than 200 dedicated cancer hospitals serve a population of 1.4 billion; Tier 2 and Tier 3 cities are critically underserved
- 3
Radiation therapy infrastructure is the most acute bottleneck — only 1 linear accelerator per 1.5 million people nationally
- 4
Day-care chemotherapy and outpatient oncology models are achieving break-even 30–40% faster than inpatient-first formats
- 5
Public-private partnership models are emerging as the most viable entry route in state capitals outside the top 8 metros
India's Oncology Infrastructure Crisis
India's cancer burden is growing at a rate that its healthcare infrastructure is not equipped to handle. With 1.4 million new cases annually — projected to reach 2 million by 2035 — and a five-year survival rate of approximately 40% (compared to 65–70% in developed markets), the gap between cancer incidence and treatment capacity is one of the most urgent healthcare challenges in the country. The core problem is geographic concentration: the majority of India's oncology infrastructure — cancer hospitals, radiation therapy centres, and trained oncologists — is concentrated in 8–10 cities. A patient diagnosed with cancer in Patna, Bhopal, or Visakhapatnam faces a choice between travelling to a metro for treatment or accepting lower-quality local care.
Research Methodology
This report is based on primary research conducted between April and June 2026, including structured interviews with 68 oncologists and radiation oncologists across 20 cities, patient journey research with 280 cancer patients and caregivers, facility audits at 24 cancer treatment centres, and financial benchmarking of 12 dedicated cancer hospital operators.
Who Should Read This Report
This report is designed for hospital chains and healthcare investors evaluating oncology infrastructure investment; medical device and radiation therapy equipment companies assessing market opportunity; private equity firms evaluating cancer care assets; government and policy bodies planning oncology infrastructure; and pharmaceutical companies assessing oncology market access in India.
Free Download
Get the full 26-page report
Primary research, data-backed findings, and strategic recommendations — all in one PDF. Free to download.
Frequently Asked Questions
How many cancer hospitals are there in India?
India has fewer than 200 dedicated cancer hospitals — a critically low number for a population of 1.4 billion with 1.4 million new cancer cases annually. The majority are concentrated in metros and large Tier 1 cities. Most Tier 2 and Tier 3 cities have no dedicated cancer facility, forcing patients to travel for treatment.
What is the market size for cancer care in India?
India's cancer care market was estimated at approximately ₹35,000–40,000 crore in 2025, growing at 14–16% CAGR. The market includes hospital-based treatment, radiation therapy, chemotherapy drugs, diagnostics, and supportive care. The addressable market for new dedicated cancer hospital infrastructure is significantly larger when unmet demand is factored in.
Which cities have the biggest oncology infrastructure gap in India?
Based on our research, the cities with the most acute oncology infrastructure gaps — measured by cancer incidence relative to treatment capacity — include Patna, Bhopal, Raipur, Ranchi, Guwahati, Lucknow, Varanasi, Agra, Visakhapatnam, and Coimbatore. These markets combine high cancer burden with minimal organised oncology infrastructure.
Related Reports
The Catalyst Map: 22 Cities Driving India's Next Healthcare Growth Wave
Beyond the Hospital: The Emergence of Dedicated Robotic Surgery Centres
The White Space in Eye Care: Why India's Next Billion-Dollar Healthcare Opportunity Is Still Untapped
Custom Research
Need custom research on this market?
Our published reports cover broad themes. For research specific to your geography, therapy area, or competitive situation, talk to InsightRx.